CNBX Pharmaceuticals Inc. (CNBX) › Operating IncomeCNBX Pharmaceuticals Inc. (CNBX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$58.1K2014: -$216.1K2015: -$536.5K2016: -$280.7K2017: -$1.85M2018: -$3.81M2019: -$3.30M2020: -$3.04M2021: -$2.60M2022: -$2.95M2023: -$931.4K2024: -$583.1K2025: -$271.7K-$271.7K2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$271.7K+53.4%2024-$583.1K+37.4%2023-$931.4K+68.5%2022-$2.95M-13.6%2021-$2.60M+14.6%2020-$3.04M+7.9%2019-$3.30M+13.3%2018-$3.81M-105.4%2017-$1.85M-560.5%2016-$280.7K+47.7%2015-$536.5K-148.2%2014-$216.1K-271.9%2013-$58.1K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share